<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-02T02:03:21Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/31026" metadataPrefix="rdf">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/31026</identifier><datestamp>2026-02-03T11:30:04Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:riuma.uma.es:10630/31026">
      <dc:title>RNA expression changes driven by altered epigenetics status related to NASH etiology</dc:title>
      <dc:creator>Castellano Castillo, Daniel</dc:creator>
      <dc:creator>Ramos-Molina, Bruno</dc:creator>
      <dc:creator>Frutos, María Dolores</dc:creator>
      <dc:creator>Arranz-Salas, Isabel María</dc:creator>
      <dc:creator>Reyes-Engel, Armando</dc:creator>
      <dc:creator>Queipo-Ortuño, María Isabel</dc:creator>
      <dc:creator>Cardona-Díaz, Fernando</dc:creator>
      <dc:subject>Obesidad</dc:subject>
      <dc:subject>Hígado - Etiología</dc:subject>
      <dc:description>Non-alcoholic fatty liver disease (NAFLD) is a growing health problem due to the increased obesity rates, among&#xd;
other factors. In its more severe stage (NASH), inflammation, hepatocellular ballooning and fibrosis are present&#xd;
in the liver, which can further evolve to total liver dysfunction or even hepatocarcinoma. As a metabolic disease,&#xd;
is associated to environmental factors such as diet and lifestyle conditions, which in turn can influence the&#xd;
epigenetic landscape of the cells, affecting to the gene expression profile and chromatin organization. In this&#xd;
study we performed ATAC-sequencing and RNA-sequencing to interrogate the chromatin status of liver biopsies&#xd;
in subjects with and without NASH and its effects on RNA transcription and NASH etiology. NASH subjects&#xd;
showed transcriptional downregulation for lipid and glucose metabolic pathways (e.g., ABC transporters, AMPK,&#xd;
FoxO or insulin pathways). A total of 229 genes were differentially enriched (ATAC and mRNA) in NASH, which&#xd;
were mainly related to lipid transport activity, nuclear receptor-binding, dicarboxylic acid transporter, and&#xd;
PPARA lipid regulation. Interpolation of ATAC data with known liver enhancer regions showed differential&#xd;
openness at 8 enhancers, some linked to genes involved in lipid metabolism, (i.e., FASN) and glucose homeostasis&#xd;
(i.e., GCGR). In conclusion, the chromatin landscape is altered in NASH patients compared to patients without&#xd;
this liver condition. This alteration might cause mRNA changes explaining, at least partially, the etiology and&#xd;
pathophysiology of the disease.</dc:description>
      <dc:date>2024-04-15T09:14:01Z</dc:date>
      <dc:date>2024-04-15T09:14:01Z</dc:date>
      <dc:date>2024-04</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Daniel Castellano-Castillo, Bruno Ramos-Molina, María Dolores Frutos, Isabel Arranz-Salas, Armando Reyes-Engel, María Isabel Queipo-Ortuño, Fernando Cardona, RNA expression changes driven by altered epigenetics status related to NASH etiology, Biomedicine &amp; Pharmacotherapy, Volume 174, 2024, 116508, ISSN 0753-3322, https://doi.org/10.1016/j.biopha.2024.116508.</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10630/31026</dc:identifier>
      <dc:identifier>10.1016/j.biopha.2024.116508</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
      <dc:publisher>ELSEVIER</dc:publisher>
   </ow:Publication>
</rdf:RDF>
</metadata></record></GetRecord></OAI-PMH>